Dietary (Poly)phenols in Traumatic Brain Injury

Abstract

Traumatic brain injury (TBI) remains one of the leading causes of death and disability in young adults worldwide. Despite growing evidence and advances in our knowledge regarding the multifaceted pathophysiology of TBI, the underlying mechanisms, though, are still to be fully elucidated. Whereas initial brain insult involves acute and irreversible primary damage to the brain, the processes of subsequent secondary brain injury progress gradually over months to years, providing a window of opportunity for therapeutic interventions. To date, extensive research has been focused on the identification of druggable targets involved in these processes. Despite several decades of successful pre-clinical studies and very promising results, when transferred to clinics, these drugs showed, at best, modest beneficial effects, but more often, an absence of effects or even very harsh side effects in TBI patients. This reality has highlighted the need for novel approaches that will be able to respond to the complexity of the TBI and tackle TBI pathological processes on multiple levels. Recent evidence strongly indicates that nutritional interventions may provide a unique opportunity to enhance the repair processes after TBI. Dietary (poly)phenols, a big class of compounds abundantly found in fruits and vegetables, have emerged in the past few years as promising agents to be used in TBI settings due to their proven pleiotropic effects. Here, we give an overview of the pathophysiology of TBI and the underlying molecular mechanisms, followed by a state-of-the-art summary of the studies that have evaluated the efficacy of (poly)phenols administration to decrease TBI-associated damage in various animal TBI models and in a limited number of clinical trials. The current limitations on our knowledge concerning (poly)phenol effects in TBI in the pre-clinical studies are also discussed.

Chinese Dietary Indices and Glioma: New Insights of a Case–Control Study in the Chinese Population

“…In addition, it may also be related to dietary polyphenols with antioxidant activity, such as resveratrol [ 54 , 71 ], apocynum venetum polyphenols [ 72 ], etc. These substances had neuroprotective effects on the brain [ 73 ], and played a similar role in glioma, including inducing glioma cell apoptosis [ 74 ], reducing its invasiveness [ 74 ], inhibiting its proliferation through NF-κB pathway [ 72 ], and improving the efficacy of radiotherapy and temozolomide [ 71 ]. In previous studies, we also found that higher dietary resveratrol intake was associated with a reduced risk of glioma, and there was a significant nonlinear dose–response relationship between them [ 75 ], which was very similar to the relationship between resveratrol and other cancers [ 76 ].…”

Emerging Role of Plant-Based Bioactive Compounds as Therapeutics in Parkinson’s Disease

“…However, MAO-B mainly metabolizes DA and some less clinically relevant chemicals [91]. In this context, the supplementation of polyphenols to rats after post-fluid percussion injury demonstrated a promising neuroprotective action [92]. Further, research findings have also revealed that a polyphenol-rich diet normalizes brain-derived neurotrophic factor (BDNF) levels and synapsin 1-dependent synaptic plasticity.…”

Phenols as an alternative, neuroprotective, and preventive strategy for Alzheimer's disease: (mini-review and bibliometric analysis)

“…Furthermore, the implementation of standardized protocols that broaden the spectrum of analysis is essential. These protocols could include high-throughput strategies to address the chemical complexity of phenols, as allowed by in silico analyses (Carecho et al, 2023).…”